RETROSPECTIVE EVALUATION OF THERAPY WITH KETOCONAZOLE IN HORMONE-REFRACTORY PROSTATE CANCER (HRPC)

被引：0
|
作者：
Bonetta, Alberto [1 ]
Derelli, Roberto [1 ]
机构：
[1] Ist Ospitaleri Cremona, Cremona, Italy
来源：
ANTICANCER RESEARCH | 2011年 / 31卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1942 / 1943
页数：2
相关论文
共 50 条
  • [31] Hormone refractory prostate cancer (HRPC): Present and future approaches of therapy
    Di Lorenzo, G
    De Placido, S
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2006, 19 (01) : 11 - 33
  • [32] Prognostic factors for survival in patients with hormone-refractory prostate cancer (HRPC) after initial androgen deprivation therapy (ADT)
    Cho, D
    Di Blasio, CJ
    Rhee, AC
    Kattan, MW
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2003, 21 (04) : 282 - 291
  • [33] Prognostic role of chromogranin a expression for docetaxel response in metastatic hormone-refractory prostate cancer (HRPC)
    Gernone, Angela
    Trabucco, Senia
    Pagliarulo, Vincenzo
    Troccoli, Giuseppe
    Pagliarulo, Arcangelo
    ANNALS OF ONCOLOGY, 2007, 18 : 65 - 65
  • [34] Impact of nail toxicity on survival of patients with hormone-refractory prostate cancer (HRPC) treated with docetaxel
    Scotte, F.
    Banu, E.
    Medioni, J.
    Boudraoui, M.
    Tourani, J. M.
    Banu, A.
    Oudard, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [35] Predictive value of the clinically and scintigraphically important bone lesions in hormone-refractory prostate cancer (HRPC)
    Athanasios Zafeirakis
    Georgios S. Limouris
    Clinical and Translational Oncology, 2009, 11 : 773 - 774
  • [36] A multivariate prognostic nomogram incorporating PSA kinetics in hormone-refractory metastatic prostate cancer (HRPC)
    Eisenberger, M.
    Garrett-Mayer, E. S.
    Yang, Y. Ou
    de Wit, R.
    Tannock, I.
    Armstrong, A. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [37] Predictive value of the clinically and scintigraphically important bone lesions in hormone-refractory prostate cancer (HRPC)
    Zafeirakis, Athanasios
    Limouris, Georgios S.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (11): : 773 - 774
  • [38] LOW-DOSE KETOCONAZOLE IN HORMONE REFRACTORY PROSTATE CANCER PATIENTS (HRPC): A SINGLE INSTITUTION EXPERIENCE
    Romero, J.
    Rodriguez, A.
    Villacampa, F.
    Duarte, J. M.
    Cabrera, F.
    Blanco, M.
    Sepulveda, J.
    Rodriguez, A.
    Castellano, D.
    Leiva, O.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 132 - 132
  • [39] Chemotherapy of the hormone-refractory prostate cancer
    Heine, K
    Wolff, JM
    AKTUELLE UROLOGIE, 2004, 35 (03) : 209 - 214
  • [40] Management of hormone-refractory prostate cancer
    Dogliotti, L
    Mosca, A
    TUMORI, 2003, : S147 - S149
12345